Table 1.
Baseline demographic characteristics of cervical cancer patients in Botswana 2013–2020.
| Characteristic | Total | All |
|---|---|---|
| N = 1043 (100%) | ||
| Age (years) | 1042 | 47 (40–58) |
| 21–39 | 227 (21.8%) | |
| 40–59 | 575 (55.1%) | |
| >60 | 240 (23.0%) | |
| HIV characteristics | ||
| HIV status | 1025 | |
| Seronegative | 311 (29.8%) | |
| Seropositive | 714 (68.5%) | |
| CD4 (cells/μL) | 544/714 | 429.5 (240.0–619.5) |
| <200 | 96 (13.4%) | |
| ≥200-<350 | 125 (17.5%) | |
| ≥350-<500 | 107 (15.0%) | |
| ≥500 | 216 (30.3%) | |
| Viral load (cells/μL) | 487/714 | |
| <400 (Undetectable) | 396 (55.5%) | |
| ≥400 (Detectable) | 91 (12.7%) | |
| On antiretroviral therapy | 704/714 | 676 (94.7%) |
| Treatment characteristics | 1043 | |
| Surgery | 58 (5.6%) | |
| Chemotherapy | 12 (1.2%) | |
| Radiation therapy | 341 (32.7%) | |
| Chemoradiation | 531 (50.9%) | |
| Surgery + Chemotherapy | 8 (0.8%) | |
| Surgery + Radiation therapy | 7 (0.7%) | |
| Surgery + Chemoradiation | 10 (1.0%) | |
| No treatment | 76 (7.3%) | |
| Disease stage | 1017 | |
| I (IA, IA1, IA2) | 45 (4.3%) | |
| I (IB, IB1, IB2, IB3) | 128 (12.3%) | |
| II (IIA, IIB) | 388 (37.2%) | |
| III (IIIA, IIIB, IIIC) | 368 (35.3%) | |
| IV (IVA, IVB) | 88 (8.4%) | |
| Marital status | 1042 | |
| Single | 669 (64.1%) | |
| Married/partnered | 240 (23.0%) | |
| Divorced/widowed | 133 (12.8%) | |
| Previously screened for cervical cancer | 1003 | 588 (56.4%) |
| Distance from treatment facility (km) | 1025 | |
| <100 | 478 (45.8%) | |
| 100–500 | 463 (44.4%) | |
| >500 | 84 (8.1%) | |
| Baseline laboratory values | ||
| Creatinine (μmol/L) | 962 | 60 (50–75) |
| Hemoglobin (g/dL) | 974 | 11.3 (9.5–12.6) |
| ≤10 | 313 (30%) | |
| >10 | 661 (63.4%) | |
| Absolute neutrophil count (×109/L) | 961 | 3.9 (2.4–6.2) |
| White blood cell count (×109/L) | 962 | 6.4 (4.7–8.6) |
| Albumin (g/L) | 656 | 39 (34.3–42.2) |
| Karnofsky performance status score | 1011 | |
| ≥90 | 757 (72.6%) | |
| <90 | 254 (24.4%) |
Values are presented as number (percentage) or median (interquartile range).
Abbreviations: HIV = human immunodeficiency virus.
Normal laboratory ranges: Creatinine (53–97 μmol/L); Hemoglobin (12.4–16.7 g/dL); Absolute neutrophil count (2.0–7.5 × 109/L); White blood cell count (4–12 × 109/L); Albumin (35–50 g/L).